412
Participants
Start Date
June 30, 2005
Primary Completion Date
November 30, 2006
Study Completion Date
April 30, 2007
TH9507
UCLA School of Medicine, Los Angeles
Office of Dr. Michael Somero, Palm Springs
UCSD Medical Center, San Diego
Kaiser Permanente, San Francisco
AIDS Research Alliance, West Hollywood
Capital Medical Associates, Washington D.C.
Bach & Godofsky, Bradenton
Office of Dr. Gary Richmond, Fort Lauderdale
Care Resource Miami, Miami
Orlando Immunology Center, Orlando
Infectious Disease Associates, Sarasota
Treasure Coast Infectious Disease Consultant (TDIDC), Vero Beach
AIDS Research Consortium Atlanta (ARCA), Atlanta
Northern Healthcare, Chicago
Rush University Medical Center, Chicago
Indiana University Department of Medicine, Indianapolis
Institute of Human Virology, Baltimore
Johns Hopkins University School of Medicine, Baltimore
Community Research Initiative of New England, Boston
Massachusetts General Hospital, Boston
Tufts University School of Medicine, Boston
Community Research Initiative of New England (CRI West), Springfield
Hennepin County Medical Centre, Minneapolis
AIDS Community Research Initiative of America, New York
Bellevue Hospital Center New York University, New York
St Luke's Roosevelt Hospital Centre, New York
St Vincent Catholic Medical Centre, New York
University of Cincinnati Medical Center, Cincinnati
Fanno Creek Clinic, LLC, Portland
Drexel University College of Medicine, Philadelphia
Central Texas Clinical Research, Austin
Dallas VA Medical Centre, Dallas
The University of Texas Medical School, Houston
Infectious Disease Physicians Inc., Annandale
Swedish Medical Center, Seattle
Southern Alberta Clinic, Calgary
St-Paul's Hospital, Vancouver
Sunnybrook and Women College Health Sciences Centre, Toronto
Windsor Regional Hospital, Windsor
Clinique Médicale du Quartier Latin, Montreal
Clinique Médicale L'Actuel, Montreal
Montreal General Hospital, Montreal
Lead Sponsor
Theratechnologies
INDUSTRY